Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease ; volume:14 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (6.8.2024), 1-11, 12.2024
- Urheber
-
Zhang, Yanjia Jason
Bousvaros, Athos
Docktor, Michael
Kaplan, Abby L.
Rufo, Paul A.
Leier, McKenzie
Weatherly, Madison
Zimmerman, Lori
Nguyen, Le Thanh Tu
Barton, Brenda
Russell, George
Alm, Eric J.
Kahn, Stacy A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-68619-w
- URN
-
urn:nbn:de:101:1-2410262118545.472935037889
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Yanjia Jason
- Bousvaros, Athos
- Docktor, Michael
- Kaplan, Abby L.
- Rufo, Paul A.
- Leier, McKenzie
- Weatherly, Madison
- Zimmerman, Lori
- Nguyen, Le Thanh Tu
- Barton, Brenda
- Russell, George
- Alm, Eric J.
- Kahn, Stacy A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients
Assessment of fecal bacterial viability and diversity in fresh and frozen fecal microbiota transplant (FMT) product in horses
Evaluation of fecal Lactobacillus populations in dogs with idiopathic epilepsy: a pilot study
Esmolol increases the fecal abundance of Lactobacillus in a rat model of sepsis
Bloom
Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients
Assessment of fecal bacterial viability and diversity in fresh and frozen fecal microbiota transplant (FMT) product in horses
Evaluation of fecal Lactobacillus populations in dogs with idiopathic epilepsy: a pilot study
Esmolol increases the fecal abundance of Lactobacillus in a rat model of sepsis
Bloom
Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients
Assessment of fecal bacterial viability and diversity in fresh and frozen fecal microbiota transplant (FMT) product in horses
Evaluation of fecal Lactobacillus populations in dogs with idiopathic epilepsy: a pilot study
Esmolol increases the fecal abundance of Lactobacillus in a rat model of sepsis
Bloom
Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients